Expression of NRP-1 and NRP-2 in Endometrial Cancer
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
BACKGROUND: Neuropilins (NRPs) participate in many processes related to cancer development such as angiogenesis, lymphangiogenesis and metastasis. Although endometrial cancer is one of the most common gynecological cancers, it has not been studied in terms of NRPs expression.
OBJECTIVE: The aim of this study was to investigate the potential utility of NRPs as important factors in the diagnosis and treatment of endometrial cancer.
METHODS: Our study consisted of 45 women diagnosed with endometrial cancer at the following degrees of histological differentiation: G1, 17; G2, 15; G3, 13 cases. The control group included 15 women without neoplastic changes. The immunohistochemical reactions were evaluated using light microscopy.
RESULTS: We did not detect the expression of NRP-1 and NRP-2 in the control group. NRP-1 expression was found exclusively in cancer cells. It was higher in G2 and G3 and reached about 190% of G1. NRP-2 expression was observed in the endothelium and was similar across all three cancer grades. In cancer cells, NRP-2 expression increased with the degree of histological differentiation.
CONCLUSION: NRP1 and NRP2 are candidates for complementary diagnostic molecular markers and promising new targets for molecular, personalized anticancer therapies.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
|---|---|
| Enthalten in: |
Current pharmaceutical biotechnology - 20(2019), 3 vom: 26., Seite 254-260 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Oplawski, Marcin [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 30.07.2019 Date Revised 10.05.2021 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.2174/1389201020666190219121602 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM294310924 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM294310924 | ||
| 003 | DE-627 | ||
| 005 | 20231225081218.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2174/1389201020666190219121602 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0981.xml |
| 035 | |a (DE-627)NLM294310924 | ||
| 035 | |a (NLM)30806307 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Oplawski, Marcin |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Expression of NRP-1 and NRP-2 in Endometrial Cancer |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 30.07.2019 | ||
| 500 | |a Date Revised 10.05.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
| 520 | |a BACKGROUND: Neuropilins (NRPs) participate in many processes related to cancer development such as angiogenesis, lymphangiogenesis and metastasis. Although endometrial cancer is one of the most common gynecological cancers, it has not been studied in terms of NRPs expression | ||
| 520 | |a OBJECTIVE: The aim of this study was to investigate the potential utility of NRPs as important factors in the diagnosis and treatment of endometrial cancer | ||
| 520 | |a METHODS: Our study consisted of 45 women diagnosed with endometrial cancer at the following degrees of histological differentiation: G1, 17; G2, 15; G3, 13 cases. The control group included 15 women without neoplastic changes. The immunohistochemical reactions were evaluated using light microscopy | ||
| 520 | |a RESULTS: We did not detect the expression of NRP-1 and NRP-2 in the control group. NRP-1 expression was found exclusively in cancer cells. It was higher in G2 and G3 and reached about 190% of G1. NRP-2 expression was observed in the endothelium and was similar across all three cancer grades. In cancer cells, NRP-2 expression increased with the degree of histological differentiation | ||
| 520 | |a CONCLUSION: NRP1 and NRP2 are candidates for complementary diagnostic molecular markers and promising new targets for molecular, personalized anticancer therapies | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Tumor growth | |
| 650 | 4 | |a cancer grade | |
| 650 | 4 | |a endometrial cancer | |
| 650 | 4 | |a endothelium | |
| 650 | 4 | |a molecular marker | |
| 650 | 4 | |a neuropilins (NRPs). | |
| 650 | 7 | |a Biomarkers, Tumor |2 NLM | |
| 650 | 7 | |a NRP1 protein, human |2 NLM | |
| 650 | 7 | |a Neuropilin-2 |2 NLM | |
| 650 | 7 | |a neuropilin-2, human |2 NLM | |
| 650 | 7 | |a Neuropilin-1 |2 NLM | |
| 650 | 7 | |a 144713-63-3 |2 NLM | |
| 700 | 1 | |a Dziobek, Konrad |e verfasserin |4 aut | |
| 700 | 1 | |a Grabarek, Beniamin |e verfasserin |4 aut | |
| 700 | 1 | |a Zmarzły, Nikola |e verfasserin |4 aut | |
| 700 | 1 | |a Dąbruś, Dariusz |e verfasserin |4 aut | |
| 700 | 1 | |a Januszyk, Piotr |e verfasserin |4 aut | |
| 700 | 1 | |a Brus, Ryszard |e verfasserin |4 aut | |
| 700 | 1 | |a Tomala, Barbara |e verfasserin |4 aut | |
| 700 | 1 | |a Boroń, Dariusz |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current pharmaceutical biotechnology |d 2000 |g 20(2019), 3 vom: 26., Seite 254-260 |w (DE-627)NLM11369072X |x 1873-4316 |7 nnns |
| 773 | 1 | 8 | |g volume:20 |g year:2019 |g number:3 |g day:26 |g pages:254-260 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2174/1389201020666190219121602 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 20 |j 2019 |e 3 |b 26 |h 254-260 | ||